Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Etanercept and Venous Thromboembolism: A Case Series
Link ID 23239
Title Etanercept and Venous Thromboembolism: A Case Series
Url http://www.medscape.com/viewarticle/717167?src=rss
Description Three arthritis patients taking Etanercept, an anti-TNF agent, present with deep vein thrombosis (DVT.) Journal of Medical Case Reports
Category Articles > Rheumatology
Keywords
Date Mar 13, 2010
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Rheumatology
1. Natural Autoantibodies Reactive With Glycosaminoglycansin Rheumatoid Arthritis
  Although natural autoantibodies constitute the predominant portion of circulating immunoglobulins, they have received little attention lately, and their precise role remains largely unknown.
Arthritis Research & Therapy
Category:   Articles > Rheumatology


2. Safe Adalimumab Therapy for Rheumatoid Arthritis in a Patient With Pre-existing Multiple Myeloma
  Rheumatoid arthritis is treated effectively with anti-tumor necrosis factor but with a possible risk of malignancy. How might treatment be safe and effective in patients with preexisting malignancies?
Nature Clinical Practice Rheumatology
Category:   Articles > Rheumatology


3. Slow-Release NSAIDs Pose Greater Risk of GI Bleeding
  What types of NSAIDs can cause the greatest gastrointestinal risk? Arthritis & Rheumatism Research News Alerts
Category:   Articles > Rheumatology


4. Combination Therapy Relieves Symptoms of Fibromyalgia Syndrome
  A meta-analysis of nine randomized, controlled trials shows that multicomponent therapy benefits patients with fibromyalgia syndrome, German researchers report in the February 15th issue of Arthritis and Rheumatism. Reuters Health Information
Category:   Articles > Rheumatology


5. Peptide P140 a Promising Treatment for SLE
  Immunotherapy with the novel investigational agent spliceosomal peptide P140 (IPP-201101; Lupuzor) safely improves the clinical and biological status of patients with systemic lupus erythematosus (SLE), according to results of an early phase II clinical trial. Reuters Health Information
Category:   Articles > Rheumatology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS